mouse igm anti forebrain surface embryonic marker 1 Search Results


96
Santa Cruz Biotechnology committed myoblasts marker
Committed Myoblasts Marker, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+igm+anti+forebrain+surface+embryonic+marker+1/MyoD+Antibody/pmc05951577-65-50-55
Average 96 stars, based on 1 article reviews
committed myoblasts marker - by Bioz Stars, 2026-10
96/100 stars
  Buy from Supplier

90
Promega α-beta iii tubulin antibody
(A) Alignment analysis of predicted amino acid sequences of ANKK1 kinase domain in Mus Musculus (GenBank: AAI45079.1) and Homo sapiens (NP_848605.1) and identification of NLS and NES. Shading indicates 100% sequence identity. The kinase domain is underlined. Highly hydrophobic amino acids in NESs are marked in bold. (B) ANKK1 (α-STk2) and α-ACTININ immunostaining of C2C12 myoblasts in differentiation (24–48 h) treated with 2 ng/ml LMB 24 h before fixed. Scale bar: 25 μm. Images were taken from confocal optical sections that are representative for the group averages. (C) Quantification of ANKK1 fluorescence intensity (a.u) in nucleus (N = 3) and (D) fusion index (N = 3). (E) Western blot of subcellular C2C12 fractions using α–STk2 and α–MyoD. β-ACTIN was used as control and <t>α-TUBULIN</t> as cytosolic marker. (F) Western blot bands were quantified using the ImageJ 1.45v software and the relative expression was represented related to β-ACTIN value. p < 0.05: *; p < 0.01: **; p < 0.001: ***. a.u: arbitrary units; N: Nucleus; C: Cytoplasm.
α Beta Iii Tubulin Antibody, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+igm+anti+forebrain+surface+embryonic+marker+1/%CE%B1+beta+iii+tubulin+antibody/pmc05951577-65-7-16
Average 90 stars, based on 1 article reviews
α-beta iii tubulin antibody - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

92
Developmental Studies Hybridoma Bank anti-neural precursor cells
(A) Alignment analysis of predicted amino acid sequences of ANKK1 kinase domain in Mus Musculus (GenBank: AAI45079.1) and Homo sapiens (NP_848605.1) and identification of NLS and NES. Shading indicates 100% sequence identity. The kinase domain is underlined. Highly hydrophobic amino acids in NESs are marked in bold. (B) ANKK1 (α-STk2) and α-ACTININ immunostaining of C2C12 myoblasts in differentiation (24–48 h) treated with 2 ng/ml LMB 24 h before fixed. Scale bar: 25 μm. Images were taken from confocal optical sections that are representative for the group averages. (C) Quantification of ANKK1 fluorescence intensity (a.u) in nucleus (N = 3) and (D) fusion index (N = 3). (E) Western blot of subcellular C2C12 fractions using α–STk2 and α–MyoD. β-ACTIN was used as control and <t>α-TUBULIN</t> as cytosolic marker. (F) Western blot bands were quantified using the ImageJ 1.45v software and the relative expression was represented related to β-ACTIN value. p < 0.05: *; p < 0.01: **; p < 0.001: ***. a.u: arbitrary units; N: Nucleus; C: Cytoplasm.
Anti Neural Precursor Cells, supplied by Developmental Studies Hybridoma Bank, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+igm+anti+forebrain+surface+embryonic+marker+1/anti-neural+precursor+cells/custom%40forse%2E1%4017038668
Average 92 stars, based on 1 article reviews
anti-neural precursor cells - by Bioz Stars, 2026-10
92/100 stars
  Buy from Supplier

96
Santa Cruz Biotechnology α alpha actinin
(A) ANKK1 (α-STk2) and <t>ACTININ</t> immunostaining of C2C12 cells during myogenic differentiation. D0: proliferative myoblast; D3: myoblasts in differentiation; D6: myotubes. (B) Quantification of nuclear ANKK1 fluorescence intensity (a.u.) (N = 3) (C) Western blot analysis of C2C12 subcellular fractions. β-ACTIN was used as control and α-LAMIN A/C as nuclear marker (N = 1). (D) Rhabdomyosarcoma (RD) myoblasts differentiation, (E) quantification of nuclear ANKK1 (N = 3) and (F) Western blot of subcellular fractions (N = 1). (G) Immunostaining of ANKK1 with PAX7 and MYOD in C2C12 cells, (left) and quantification of positive nuclei for ANKK1, PAX7 and MYOD along myogenic differentiation (right, N = 3). Images were taken from confocal optical sections that are representative for the group averages. Scale bar: 25 μm p < 0.05: *; p < 0.01: **; p < 0.001: ***. D: Days after induction of differentiation; a.u: arbitrary units; N: Nucleus; C: Cytoplasm.
α Alpha Actinin, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+igm+anti+forebrain+surface+embryonic+marker+1/%CE%B1-actinin+Antibody/pmc05951577-65-34-55
Average 96 stars, based on 1 article reviews
α alpha actinin - by Bioz Stars, 2026-10
96/100 stars
  Buy from Supplier

94
Bio-Techne corporation human/mouse ssea-4 antibody
(A) ANKK1 (α-STk2) and <t>ACTININ</t> immunostaining of C2C12 cells during myogenic differentiation. D0: proliferative myoblast; D3: myoblasts in differentiation; D6: myotubes. (B) Quantification of nuclear ANKK1 fluorescence intensity (a.u.) (N = 3) (C) Western blot analysis of C2C12 subcellular fractions. β-ACTIN was used as control and α-LAMIN A/C as nuclear marker (N = 1). (D) Rhabdomyosarcoma (RD) myoblasts differentiation, (E) quantification of nuclear ANKK1 (N = 3) and (F) Western blot of subcellular fractions (N = 1). (G) Immunostaining of ANKK1 with PAX7 and MYOD in C2C12 cells, (left) and quantification of positive nuclei for ANKK1, PAX7 and MYOD along myogenic differentiation (right, N = 3). Images were taken from confocal optical sections that are representative for the group averages. Scale bar: 25 μm p < 0.05: *; p < 0.01: **; p < 0.001: ***. D: Days after induction of differentiation; a.u: arbitrary units; N: Nucleus; C: Cytoplasm.
Human/Mouse Ssea 4 Antibody, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+igm+anti+forebrain+surface+embryonic+marker+1/Human%2FMouse+SSEA-4+Antibody/bio-techne+corporation___mab1435
Average 94 stars, based on 1 article reviews
human/mouse ssea-4 antibody - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

93
Bio-Techne corporation human/mouse mog antibody
(A) ANKK1 (α-STk2) and <t>ACTININ</t> immunostaining of C2C12 cells during myogenic differentiation. D0: proliferative myoblast; D3: myoblasts in differentiation; D6: myotubes. (B) Quantification of nuclear ANKK1 fluorescence intensity (a.u.) (N = 3) (C) Western blot analysis of C2C12 subcellular fractions. β-ACTIN was used as control and α-LAMIN A/C as nuclear marker (N = 1). (D) Rhabdomyosarcoma (RD) myoblasts differentiation, (E) quantification of nuclear ANKK1 (N = 3) and (F) Western blot of subcellular fractions (N = 1). (G) Immunostaining of ANKK1 with PAX7 and MYOD in C2C12 cells, (left) and quantification of positive nuclei for ANKK1, PAX7 and MYOD along myogenic differentiation (right, N = 3). Images were taken from confocal optical sections that are representative for the group averages. Scale bar: 25 μm p < 0.05: *; p < 0.01: **; p < 0.001: ***. D: Days after induction of differentiation; a.u: arbitrary units; N: Nucleus; C: Cytoplasm.
Human/Mouse Mog Antibody, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+igm+anti+forebrain+surface+embryonic+marker+1/Human%2FMouse+MOG+Antibody/bio-techne+corporation___mab2439
Average 93 stars, based on 1 article reviews
human/mouse mog antibody - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

96
Santa Cruz Biotechnology il 6
(A) ANKK1 (α-STk2) and <t>ACTININ</t> immunostaining of C2C12 cells during myogenic differentiation. D0: proliferative myoblast; D3: myoblasts in differentiation; D6: myotubes. (B) Quantification of nuclear ANKK1 fluorescence intensity (a.u.) (N = 3) (C) Western blot analysis of C2C12 subcellular fractions. β-ACTIN was used as control and α-LAMIN A/C as nuclear marker (N = 1). (D) Rhabdomyosarcoma (RD) myoblasts differentiation, (E) quantification of nuclear ANKK1 (N = 3) and (F) Western blot of subcellular fractions (N = 1). (G) Immunostaining of ANKK1 with PAX7 and MYOD in C2C12 cells, (left) and quantification of positive nuclei for ANKK1, PAX7 and MYOD along myogenic differentiation (right, N = 3). Images were taken from confocal optical sections that are representative for the group averages. Scale bar: 25 μm p < 0.05: *; p < 0.01: **; p < 0.001: ***. D: Days after induction of differentiation; a.u: arbitrary units; N: Nucleus; C: Cytoplasm.
Il 6, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+igm+anti+forebrain+surface+embryonic+marker+1/IL-6/pm24907401-83-7-27
Average 96 stars, based on 1 article reviews
il 6 - by Bioz Stars, 2026-10
96/100 stars
  Buy from Supplier

96
Santa Cruz Biotechnology mouse anti gfap
(A) ANKK1 (α-STk2) and <t>ACTININ</t> immunostaining of C2C12 cells during myogenic differentiation. D0: proliferative myoblast; D3: myoblasts in differentiation; D6: myotubes. (B) Quantification of nuclear ANKK1 fluorescence intensity (a.u.) (N = 3) (C) Western blot analysis of C2C12 subcellular fractions. β-ACTIN was used as control and α-LAMIN A/C as nuclear marker (N = 1). (D) Rhabdomyosarcoma (RD) myoblasts differentiation, (E) quantification of nuclear ANKK1 (N = 3) and (F) Western blot of subcellular fractions (N = 1). (G) Immunostaining of ANKK1 with PAX7 and MYOD in C2C12 cells, (left) and quantification of positive nuclei for ANKK1, PAX7 and MYOD along myogenic differentiation (right, N = 3). Images were taken from confocal optical sections that are representative for the group averages. Scale bar: 25 μm p < 0.05: *; p < 0.01: **; p < 0.001: ***. D: Days after induction of differentiation; a.u: arbitrary units; N: Nucleus; C: Cytoplasm.
Mouse Anti Gfap, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+igm+anti+forebrain+surface+embryonic+marker+1/GFAP+Antibody/pm24907401-83-24-27
Average 96 stars, based on 1 article reviews
mouse anti gfap - by Bioz Stars, 2026-10
96/100 stars
  Buy from Supplier

93
Vector Laboratories biotinylated griffonia bandeira simplicifolia lectin b4
(A) ANKK1 (α-STk2) and <t>ACTININ</t> immunostaining of C2C12 cells during myogenic differentiation. D0: proliferative myoblast; D3: myoblasts in differentiation; D6: myotubes. (B) Quantification of nuclear ANKK1 fluorescence intensity (a.u.) (N = 3) (C) Western blot analysis of C2C12 subcellular fractions. β-ACTIN was used as control and α-LAMIN A/C as nuclear marker (N = 1). (D) Rhabdomyosarcoma (RD) myoblasts differentiation, (E) quantification of nuclear ANKK1 (N = 3) and (F) Western blot of subcellular fractions (N = 1). (G) Immunostaining of ANKK1 with PAX7 and MYOD in C2C12 cells, (left) and quantification of positive nuclei for ANKK1, PAX7 and MYOD along myogenic differentiation (right, N = 3). Images were taken from confocal optical sections that are representative for the group averages. Scale bar: 25 μm p < 0.05: *; p < 0.01: **; p < 0.001: ***. D: Days after induction of differentiation; a.u: arbitrary units; N: Nucleus; C: Cytoplasm.
Biotinylated Griffonia Bandeira Simplicifolia Lectin B4, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+igm+anti+forebrain+surface+embryonic+marker+1/Biotinylated+Griffonia+(Bandeiraea)+Simplicifolia+Lectin+II+(GSL+II%2C+BSL+II)/pm24907401-83-41-49
Average 93 stars, based on 1 article reviews
biotinylated griffonia bandeira simplicifolia lectin b4 - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

96
Santa Cruz Biotechnology anti rabbit brainderived nerve growth factor bdnf
(A) ANKK1 (α-STk2) and <t>ACTININ</t> immunostaining of C2C12 cells during myogenic differentiation. D0: proliferative myoblast; D3: myoblasts in differentiation; D6: myotubes. (B) Quantification of nuclear ANKK1 fluorescence intensity (a.u.) (N = 3) (C) Western blot analysis of C2C12 subcellular fractions. β-ACTIN was used as control and α-LAMIN A/C as nuclear marker (N = 1). (D) Rhabdomyosarcoma (RD) myoblasts differentiation, (E) quantification of nuclear ANKK1 (N = 3) and (F) Western blot of subcellular fractions (N = 1). (G) Immunostaining of ANKK1 with PAX7 and MYOD in C2C12 cells, (left) and quantification of positive nuclei for ANKK1, PAX7 and MYOD along myogenic differentiation (right, N = 3). Images were taken from confocal optical sections that are representative for the group averages. Scale bar: 25 μm p < 0.05: *; p < 0.01: **; p < 0.001: ***. D: Days after induction of differentiation; a.u: arbitrary units; N: Nucleus; C: Cytoplasm.
Anti Rabbit Brainderived Nerve Growth Factor Bdnf, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+igm+anti+forebrain+surface+embryonic+marker+1/BDNF/pm25889458-97-6-29
Average 96 stars, based on 1 article reviews
anti rabbit brainderived nerve growth factor bdnf - by Bioz Stars, 2026-10
96/100 stars
  Buy from Supplier

95
Vector Laboratories biotinylated griffonia bandeira simplicifolia isolectin b4
(A) ANKK1 (α-STk2) and <t>ACTININ</t> immunostaining of C2C12 cells during myogenic differentiation. D0: proliferative myoblast; D3: myoblasts in differentiation; D6: myotubes. (B) Quantification of nuclear ANKK1 fluorescence intensity (a.u.) (N = 3) (C) Western blot analysis of C2C12 subcellular fractions. β-ACTIN was used as control and α-LAMIN A/C as nuclear marker (N = 1). (D) Rhabdomyosarcoma (RD) myoblasts differentiation, (E) quantification of nuclear ANKK1 (N = 3) and (F) Western blot of subcellular fractions (N = 1). (G) Immunostaining of ANKK1 with PAX7 and MYOD in C2C12 cells, (left) and quantification of positive nuclei for ANKK1, PAX7 and MYOD along myogenic differentiation (right, N = 3). Images were taken from confocal optical sections that are representative for the group averages. Scale bar: 25 μm p < 0.05: *; p < 0.01: **; p < 0.001: ***. D: Days after induction of differentiation; a.u: arbitrary units; N: Nucleus; C: Cytoplasm.
Biotinylated Griffonia Bandeira Simplicifolia Isolectin B4, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+igm+anti+forebrain+surface+embryonic+marker+1/Biotinylated+Griffonia+Simplicifolia+Lectin+I+(GSL+I)+isolectin+B4/pm25889458-97-42-51
Average 95 stars, based on 1 article reviews
biotinylated griffonia bandeira simplicifolia isolectin b4 - by Bioz Stars, 2026-10
95/100 stars
  Buy from Supplier

90
ImmunoStar inc glial fibrilary acidic protein (gfap
(A) ANKK1 (α-STk2) and <t>ACTININ</t> immunostaining of C2C12 cells during myogenic differentiation. D0: proliferative myoblast; D3: myoblasts in differentiation; D6: myotubes. (B) Quantification of nuclear ANKK1 fluorescence intensity (a.u.) (N = 3) (C) Western blot analysis of C2C12 subcellular fractions. β-ACTIN was used as control and α-LAMIN A/C as nuclear marker (N = 1). (D) Rhabdomyosarcoma (RD) myoblasts differentiation, (E) quantification of nuclear ANKK1 (N = 3) and (F) Western blot of subcellular fractions (N = 1). (G) Immunostaining of ANKK1 with PAX7 and MYOD in C2C12 cells, (left) and quantification of positive nuclei for ANKK1, PAX7 and MYOD along myogenic differentiation (right, N = 3). Images were taken from confocal optical sections that are representative for the group averages. Scale bar: 25 μm p < 0.05: *; p < 0.01: **; p < 0.001: ***. D: Days after induction of differentiation; a.u: arbitrary units; N: Nucleus; C: Cytoplasm.
Glial Fibrilary Acidic Protein (Gfap, supplied by ImmunoStar inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+igm+anti+forebrain+surface+embryonic+marker+1/glial+fibrillary+acidic+protein++gfap++antibody/pmc02744946-174-42-49
Average 90 stars, based on 1 article reviews
glial fibrilary acidic protein (gfap - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results


(A) Alignment analysis of predicted amino acid sequences of ANKK1 kinase domain in Mus Musculus (GenBank: AAI45079.1) and Homo sapiens (NP_848605.1) and identification of NLS and NES. Shading indicates 100% sequence identity. The kinase domain is underlined. Highly hydrophobic amino acids in NESs are marked in bold. (B) ANKK1 (α-STk2) and α-ACTININ immunostaining of C2C12 myoblasts in differentiation (24–48 h) treated with 2 ng/ml LMB 24 h before fixed. Scale bar: 25 μm. Images were taken from confocal optical sections that are representative for the group averages. (C) Quantification of ANKK1 fluorescence intensity (a.u) in nucleus (N = 3) and (D) fusion index (N = 3). (E) Western blot of subcellular C2C12 fractions using α–STk2 and α–MyoD. β-ACTIN was used as control and α-TUBULIN as cytosolic marker. (F) Western blot bands were quantified using the ImageJ 1.45v software and the relative expression was represented related to β-ACTIN value. p < 0.05: *; p < 0.01: **; p < 0.001: ***. a.u: arbitrary units; N: Nucleus; C: Cytoplasm.

Journal: PLoS ONE

Article Title: ANKK1 is found in myogenic precursors and muscle fibers subtypes with glycolytic metabolism

doi: 10.1371/journal.pone.0197254

Figure Lengend Snippet: (A) Alignment analysis of predicted amino acid sequences of ANKK1 kinase domain in Mus Musculus (GenBank: AAI45079.1) and Homo sapiens (NP_848605.1) and identification of NLS and NES. Shading indicates 100% sequence identity. The kinase domain is underlined. Highly hydrophobic amino acids in NESs are marked in bold. (B) ANKK1 (α-STk2) and α-ACTININ immunostaining of C2C12 myoblasts in differentiation (24–48 h) treated with 2 ng/ml LMB 24 h before fixed. Scale bar: 25 μm. Images were taken from confocal optical sections that are representative for the group averages. (C) Quantification of ANKK1 fluorescence intensity (a.u) in nucleus (N = 3) and (D) fusion index (N = 3). (E) Western blot of subcellular C2C12 fractions using α–STk2 and α–MyoD. β-ACTIN was used as control and α-TUBULIN as cytosolic marker. (F) Western blot bands were quantified using the ImageJ 1.45v software and the relative expression was represented related to β-ACTIN value. p < 0.05: *; p < 0.01: **; p < 0.001: ***. a.u: arbitrary units; N: Nucleus; C: Cytoplasm.

Article Snippet: The following mouse monoclonal antibodies were used: α-beta III Tubulin as a neuronal marker (1:7000, Tubb3, Promega), α–embryonic Myosin heavy chain (eMyHC) as embryonic myoblasts marker (1:80, clone F1.652-s, Developmental Studies Hybridoma Bank, DSHB); α-alpha-Actinin as myotubes marker (1:200, A7732, Sigma-Aldrich); α-Pax7 as SCs marker (1:50, Pax7-c, DSHB); α-MyoD as committed myoblasts marker (1:200, sc-32758, Santa Cruz Biotechnology).

Techniques: Sequencing, Immunostaining, Fluorescence, Western Blot, Control, Marker, Software, Expressing

(A) Representative images for the group averages of IHC analysis of ANKK1, MyHC1 and MyHC2 in mice adult skeletal gastrocnemius serial sections and (B) colocalization of ANKK1 and MyHC2 in triceps and soleus muscles. The black asterisk indicates the same fiber. Scale bar: 50 μm. (C) Glycolysis induction in C2C12 myoblasts using HG and berberine during 24 h treatments. Oxygen consumption was assessed using a Clark-type oxygen electrode (N = 7) and lactic acid production was measured (N = 3). Relative oxygen and L-lactic acid production values are shown (±SD). (D) ANKK1 expression analysis by reverse transcriptase polymerase chain reaction (N = 3). Relative mRNA values (±SD) are shown. (E) Western blot of subcellular C1C12 fractions using α-STk2 (N = 4). β-ACTIN was used as control and α-TUBULIN as cytosolic marker. Western blot bands were quantified using the ImageJ 1.45v software and the relative expression was represented related to β-Actin value. p < 0.05: *; p < 0.01: **; p < 0.001: ***.N: nucleus; C: cytoplasm; RE: Relative Expression; Ber: berberine.

Journal: PLoS ONE

Article Title: ANKK1 is found in myogenic precursors and muscle fibers subtypes with glycolytic metabolism

doi: 10.1371/journal.pone.0197254

Figure Lengend Snippet: (A) Representative images for the group averages of IHC analysis of ANKK1, MyHC1 and MyHC2 in mice adult skeletal gastrocnemius serial sections and (B) colocalization of ANKK1 and MyHC2 in triceps and soleus muscles. The black asterisk indicates the same fiber. Scale bar: 50 μm. (C) Glycolysis induction in C2C12 myoblasts using HG and berberine during 24 h treatments. Oxygen consumption was assessed using a Clark-type oxygen electrode (N = 7) and lactic acid production was measured (N = 3). Relative oxygen and L-lactic acid production values are shown (±SD). (D) ANKK1 expression analysis by reverse transcriptase polymerase chain reaction (N = 3). Relative mRNA values (±SD) are shown. (E) Western blot of subcellular C1C12 fractions using α-STk2 (N = 4). β-ACTIN was used as control and α-TUBULIN as cytosolic marker. Western blot bands were quantified using the ImageJ 1.45v software and the relative expression was represented related to β-Actin value. p < 0.05: *; p < 0.01: **; p < 0.001: ***.N: nucleus; C: cytoplasm; RE: Relative Expression; Ber: berberine.

Article Snippet: The following mouse monoclonal antibodies were used: α-beta III Tubulin as a neuronal marker (1:7000, Tubb3, Promega), α–embryonic Myosin heavy chain (eMyHC) as embryonic myoblasts marker (1:80, clone F1.652-s, Developmental Studies Hybridoma Bank, DSHB); α-alpha-Actinin as myotubes marker (1:200, A7732, Sigma-Aldrich); α-Pax7 as SCs marker (1:50, Pax7-c, DSHB); α-MyoD as committed myoblasts marker (1:200, sc-32758, Santa Cruz Biotechnology).

Techniques: Muscles, Expressing, Reverse Transcription, Polymerase Chain Reaction, Western Blot, Control, Marker, Software

(A) ANKK1 (α-STk2) and ACTININ immunostaining of C2C12 cells during myogenic differentiation. D0: proliferative myoblast; D3: myoblasts in differentiation; D6: myotubes. (B) Quantification of nuclear ANKK1 fluorescence intensity (a.u.) (N = 3) (C) Western blot analysis of C2C12 subcellular fractions. β-ACTIN was used as control and α-LAMIN A/C as nuclear marker (N = 1). (D) Rhabdomyosarcoma (RD) myoblasts differentiation, (E) quantification of nuclear ANKK1 (N = 3) and (F) Western blot of subcellular fractions (N = 1). (G) Immunostaining of ANKK1 with PAX7 and MYOD in C2C12 cells, (left) and quantification of positive nuclei for ANKK1, PAX7 and MYOD along myogenic differentiation (right, N = 3). Images were taken from confocal optical sections that are representative for the group averages. Scale bar: 25 μm p < 0.05: *; p < 0.01: **; p < 0.001: ***. D: Days after induction of differentiation; a.u: arbitrary units; N: Nucleus; C: Cytoplasm.

Journal: PLoS ONE

Article Title: ANKK1 is found in myogenic precursors and muscle fibers subtypes with glycolytic metabolism

doi: 10.1371/journal.pone.0197254

Figure Lengend Snippet: (A) ANKK1 (α-STk2) and ACTININ immunostaining of C2C12 cells during myogenic differentiation. D0: proliferative myoblast; D3: myoblasts in differentiation; D6: myotubes. (B) Quantification of nuclear ANKK1 fluorescence intensity (a.u.) (N = 3) (C) Western blot analysis of C2C12 subcellular fractions. β-ACTIN was used as control and α-LAMIN A/C as nuclear marker (N = 1). (D) Rhabdomyosarcoma (RD) myoblasts differentiation, (E) quantification of nuclear ANKK1 (N = 3) and (F) Western blot of subcellular fractions (N = 1). (G) Immunostaining of ANKK1 with PAX7 and MYOD in C2C12 cells, (left) and quantification of positive nuclei for ANKK1, PAX7 and MYOD along myogenic differentiation (right, N = 3). Images were taken from confocal optical sections that are representative for the group averages. Scale bar: 25 μm p < 0.05: *; p < 0.01: **; p < 0.001: ***. D: Days after induction of differentiation; a.u: arbitrary units; N: Nucleus; C: Cytoplasm.

Article Snippet: The following mouse monoclonal antibodies were used: α-beta III Tubulin as a neuronal marker (1:7000, Tubb3, Promega), α–embryonic Myosin heavy chain (eMyHC) as embryonic myoblasts marker (1:80, clone F1.652-s, Developmental Studies Hybridoma Bank, DSHB); α-alpha-Actinin as myotubes marker (1:200, A7732, Sigma-Aldrich); α-Pax7 as SCs marker (1:50, Pax7-c, DSHB); α-MyoD as committed myoblasts marker (1:200, sc-32758, Santa Cruz Biotechnology).

Techniques: Immunostaining, Fluorescence, Western Blot, Control, Marker

(A) Alignment analysis of predicted amino acid sequences of ANKK1 kinase domain in Mus Musculus (GenBank: AAI45079.1) and Homo sapiens (NP_848605.1) and identification of NLS and NES. Shading indicates 100% sequence identity. The kinase domain is underlined. Highly hydrophobic amino acids in NESs are marked in bold. (B) ANKK1 (α-STk2) and α-ACTININ immunostaining of C2C12 myoblasts in differentiation (24–48 h) treated with 2 ng/ml LMB 24 h before fixed. Scale bar: 25 μm. Images were taken from confocal optical sections that are representative for the group averages. (C) Quantification of ANKK1 fluorescence intensity (a.u) in nucleus (N = 3) and (D) fusion index (N = 3). (E) Western blot of subcellular C2C12 fractions using α–STk2 and α–MyoD. β-ACTIN was used as control and α-TUBULIN as cytosolic marker. (F) Western blot bands were quantified using the ImageJ 1.45v software and the relative expression was represented related to β-ACTIN value. p < 0.05: *; p < 0.01: **; p < 0.001: ***. a.u: arbitrary units; N: Nucleus; C: Cytoplasm.

Journal: PLoS ONE

Article Title: ANKK1 is found in myogenic precursors and muscle fibers subtypes with glycolytic metabolism

doi: 10.1371/journal.pone.0197254

Figure Lengend Snippet: (A) Alignment analysis of predicted amino acid sequences of ANKK1 kinase domain in Mus Musculus (GenBank: AAI45079.1) and Homo sapiens (NP_848605.1) and identification of NLS and NES. Shading indicates 100% sequence identity. The kinase domain is underlined. Highly hydrophobic amino acids in NESs are marked in bold. (B) ANKK1 (α-STk2) and α-ACTININ immunostaining of C2C12 myoblasts in differentiation (24–48 h) treated with 2 ng/ml LMB 24 h before fixed. Scale bar: 25 μm. Images were taken from confocal optical sections that are representative for the group averages. (C) Quantification of ANKK1 fluorescence intensity (a.u) in nucleus (N = 3) and (D) fusion index (N = 3). (E) Western blot of subcellular C2C12 fractions using α–STk2 and α–MyoD. β-ACTIN was used as control and α-TUBULIN as cytosolic marker. (F) Western blot bands were quantified using the ImageJ 1.45v software and the relative expression was represented related to β-ACTIN value. p < 0.05: *; p < 0.01: **; p < 0.001: ***. a.u: arbitrary units; N: Nucleus; C: Cytoplasm.

Article Snippet: The following mouse monoclonal antibodies were used: α-beta III Tubulin as a neuronal marker (1:7000, Tubb3, Promega), α–embryonic Myosin heavy chain (eMyHC) as embryonic myoblasts marker (1:80, clone F1.652-s, Developmental Studies Hybridoma Bank, DSHB); α-alpha-Actinin as myotubes marker (1:200, A7732, Sigma-Aldrich); α-Pax7 as SCs marker (1:50, Pax7-c, DSHB); α-MyoD as committed myoblasts marker (1:200, sc-32758, Santa Cruz Biotechnology).

Techniques: Sequencing, Immunostaining, Fluorescence, Western Blot, Control, Marker, Software, Expressing